AMLX — Amylyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Apple, Hims & Hers Health, Sysco
U.S. STOCKS ON THE MOVE-Nordson, Nebius, Deere
Amylyx dips after increased $500 mln stock sale to fund blood sugar drug
Brief: Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock
U.S. RESEARCH ROUNDUP-Cogent Communications, Dollar Tree, Home Depot
Amylyx Pharma starts $350 mln equity offering to fund blood sugar drug
Brief: Amylyx Pharmaceuticals Announces $350 Million Proposed Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
Amylyx soars as blood sugar drug succeeds in late-stage trial
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics
Amylyx drug cuts low blood sugar episodes in bariatric surgery patients in key trial (updated)
Amylyx soars as blood sugar drug succeeds in late-stage trial
NASDAQ RESUMED AT 07:35 AM
Amylyx drug cuts low blood sugar episodes in bariatric surgery patients in key trial
Brief: Amylyx Says Phase 3 Trial of Avexitide For Post-Bariatric Hypoglycemia Met Main Goal
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Amylyx Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Amylyx Pharmaceuticals Q2 posts higher than expected loss